BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

1.480

-0.050 (-3.27%)

At close: May 12, 2025, 4:00 PM

1.470

-0.010 (-0.68%)

After-hours: May 12, 2025, 7:44 PM EDT

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $8.09 million as of May 12, 2025. Its market cap has decreased by -91.94% in one year.

Market Cap

8.09M

Enterprise Value

82.61M

1-Year Change

-91.94%

Ranking

#5137

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $8.09M, a decrease of -95.31%. That is a compound annual growth rate of -34.72%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	8.37M	-54.91%
Dec 31, 2024	18.56M	-78.51%
Dec 29, 2023	86.35M	-85.65%
Dec 30, 2022	601.94M	5.82%
Dec 31, 2021	568.84M	-49.47%
Dec 31, 2020	1.13B	327.27%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	659.45B
Johnson & Johnson	371.06B
UnitedHealth Group	345.29B
AbbVie	326.08B
Novo Nordisk	297.79B
Abbott Laboratories	231.82B
Novartis AG	214.71B
AstraZeneca	211.14B

Market Cap Rankings